163 related articles for article (PubMed ID: 28448592)
1. Blood type, ABO genetic variants, and ovarian cancer survival.
Cozzi GD; Levinson RT; Toole H; Snyder MR; Deng A; Crispens MA; Khabele D; Beeghly-Fadiel A
PLoS One; 2017; 12(4):e0175119. PubMed ID: 28448592
[TBL] [Abstract][Full Text] [Related]
2. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
Poole EM; Gates MA; High BA; Chanock SJ; Cramer DW; Cunningham JM; Fridley BL; Gayther SA; Goode EL; Iversen ES; Lissowska J; Palmieri Weber RT; Pharoah PD; Phelan CM; Ramus SJ; Schildkraut JM; Sutphen R; Tsai YY; Tyrer J; Vierkant RA; Wentzensen N; Yang HP; Terry KL; Tworoger SS
Cancer Causes Control; 2012 Nov; 23(11):1805-10. PubMed ID: 22961099
[TBL] [Abstract][Full Text] [Related]
3. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
[TBL] [Abstract][Full Text] [Related]
4. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Xu M; Steplowski E; Olsson ML; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Stolzenberg-Solomon RZ; Zheng W; Albanes D; Allen NE; Amundadottir L; Austin MA; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Sanchéz MJ; Sansbury L; Shu XO; Slimani N; Tobias GS; Trichopoulos D; Vineis P; Visvanathan K; Virtamo J; Wactawski-Wende J; Watters J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3140-9. PubMed ID: 20971884
[TBL] [Abstract][Full Text] [Related]
5. ABO blood group and breast cancer incidence and survival.
Gates MA; Xu M; Chen WY; Kraft P; Hankinson SE; Wolpin BM
Int J Cancer; 2012 May; 130(9):2129-37. PubMed ID: 21633955
[TBL] [Abstract][Full Text] [Related]
6. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
[TBL] [Abstract][Full Text] [Related]
7. The effects of common genetic variants in oncogenes on ovarian cancer survival.
Quaye L; Gayther SA; Ramus SJ; Di Cioccio RA; McGuire V; Hogdall E; Hogdall C; Blaakr J; Easton DF; Ponder BA; Jacobs I; Kjaer SK; Whittemore AS; Pearce CL; Pharoah PD; Song H
Clin Cancer Res; 2008 Sep; 14(18):5833-9. PubMed ID: 18794094
[TBL] [Abstract][Full Text] [Related]
8. Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study.
Rummel S; Shriver CD; Ellsworth RE
BMC Med Genet; 2012 May; 13():41. PubMed ID: 22642827
[TBL] [Abstract][Full Text] [Related]
9. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group and the risk of pancreatic cancer.
Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
[TBL] [Abstract][Full Text] [Related]
11. ABO Blood Type Has No Impact on Survival in Patients with Epithelial Ovarian Cancer.
Wang L; Yang Z; Liu Y; Wang YN; Guo JY; Wu QJ; Gong TT
J Cancer; 2018; 9(23):4334-4340. PubMed ID: 30519337
[TBL] [Abstract][Full Text] [Related]
12. ABO blood group and incidence of skin cancer.
Xie J; Qureshi AA; Li Y; Han J
PLoS One; 2010 Aug; 5(8):e11972. PubMed ID: 20694147
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
[TBL] [Abstract][Full Text] [Related]
15. ABO blood group and incidence of epithelial ovarian cancer.
Gates MA; Wolpin BM; Cramer DW; Hankinson SE; Tworoger SS
Int J Cancer; 2011 Jan; 128(2):482-6. PubMed ID: 20309936
[TBL] [Abstract][Full Text] [Related]
16. A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populations.
Karakas M; Baumert J; Kleber ME; Thorand B; Dallmeier D; Silbernagel G; Grammer TB; Rottbauer W; Meisinger C; Illig T; März W; Koenig W
PLoS One; 2012; 7(12):e51441. PubMed ID: 23300549
[TBL] [Abstract][Full Text] [Related]
17. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
18. ABO exon and intron analysis in individuals with the AweakB phenotype reveals a novel O1v-A2 hybrid allele that causes four missense mutations in the A transferase.
Hosseini-Maaf B; Hellberg A; Rodrigues MJ; Chester MA; Olsson ML
BMC Genet; 2003 Nov; 4():17. PubMed ID: 14617382
[TBL] [Abstract][Full Text] [Related]
19. Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Liu Y; Yasukawa M; Chen K; Hu L; Broaddus RR; Ding L; Mardis ER; Spellman P; Levine DA; Mills GB; Shmulevich I; Sood AK; Zhang W
JAMA Oncol; 2015 Jul; 1(4):486-94. PubMed ID: 26181259
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
